RxDoctor Payments Data

Nelcie Ecclesiastre

Family · Brooklyn, NYNPI 1679001341

Payments from drug & device makers

$1,691in general payments, 2019–2025

Across 18 payments — averaging $93.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$854
  • Axsome Therapeutics, Inc.$237
  • SK Life Science, Inc.$155
  • Otsuka America Pharmaceutical, Inc.$154
  • Sumitomo Pharma America, Inc.$148
  • AbbVie$95
  • plus $48 from 2 others

What the payments were for

  • Food & beverage$1,691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,691 in reported general payments places this provider in the 80th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$225,858
Medicare patients
308
Services billed
2,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog34$4,664
LantusInsulin Glargine,hum.Rec.Anlog60$4,653
EnuloseLactulose68$1,195
Ammonium Lactate16$734
Diclofenac Sodium18$732
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate11$648
Ondansetron OdtOndansetron21$485
Nystatin15$459
Ofloxacin12$352
Celecoxib20$341
LoperamideLoperamide Hcl26$238
Latanoprost12$150
Ondansetron HclOndansetron Hcl/Pf25$144
Midodrine Hcl12$122
Gabapentin16$72

Paid to pharmacies, not to this prescriber.

Other family in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →